Effect of coccidial challenge and vaccination on the performance, veterinary postmortem scores, and blood biochemistry of broiler chickens

Autor: Cowieson, A.J., Livingston, M.L., Nogal, B., Hoang, V., Wang, Y-.T., Crespo, R., Livingston, K.A.

Publikováno v: In Poultry Science August 2020 99(8):3831-3840

Priming antibody responses to the fusion peptide in rhesus macaques.

Autor: Cottrell CA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA.; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA., Pratap PP; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA.; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA., Cirelli KM; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.; La Jolla Institute for Immunology, La Jolla, CA, 92037, USA., Carnathan DG; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.; Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA, 30329, USA., Enemuo CA; Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA, 30329, USA., Antanasijevic A; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA.; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA., Ozorowski G; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA.; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA., Sewall LM; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA.; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA., Gao H; Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center Durham, Durham, NC, USA., Allen JD; School of Biological Sciences, University of Southampton, Southampton, SO17 1BJ, UK., Nogal B; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA.; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA., Silva M; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Bhiman J; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Pauthner M; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Irvine DJ; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Montefiori D; Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center Durham, Durham, NC, USA., Crispin M; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.; School of Biological Sciences, University of Southampton, Southampton, SO17 1BJ, UK., Burton DR; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Silvestri G; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.; Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA, 30329, USA., Crotty S; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.; La Jolla Institute for Immunology, La Jolla, CA, 92037, USA.; Division of Infectious Disease and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, CA, USA., Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA. andrew@scripps.edu.; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA. andrew@scripps.edu.

Publikováno v: NPJ vaccines [NPJ Vaccines] 2024 Jul 12; Vol. 9 (1), pp. 126. Date of Electronic Publication: 2024 Jul 12.

Helminths and skewed cytokine profiles increase tuberculin skin test positivity in Warao Amerindians

Autor: Verhagen, L.M., Hermans, P.W.M., Warris, A., de Groot, R., Maes, M., Villalba, J.A., del Nogal, B., van den Hof, S., Mughini Gras, L., van Soolingen, D., Pinelli, E., de Waard, J.H.

Publikováno v: In Tuberculosis November 2012 92(6):505-512

Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responses.

Autor: Tas JMJ; The Ragon Institute of MGH, MIT, and Harvard University, Cambridge, MA 02139, USA., Koo JH; The Ragon Institute of MGH, MIT, and Harvard University, Cambridge, MA 02139, USA., Lin YC; The Ragon Institute of MGH, MIT, and Harvard University, Cambridge, MA 02139, USA., Xie Z; The Ragon Institute of MGH, MIT, and Harvard University, Cambridge, MA 02139, USA., Steichen JM; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA., Jackson AM; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; Department of Integrative, Structural and Computational Biology, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA., Hauser BM; The Ragon Institute of MGH, MIT, and Harvard University, Cambridge, MA 02139, USA., Wang X; The Ragon Institute of MGH, MIT, and Harvard University, Cambridge, MA 02139, USA., Cottrell CA; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA., Torres JL; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; Department of Integrative, Structural and Computational Biology, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA., Warner JE; The Ragon Institute of MGH, MIT, and Harvard University, Cambridge, MA 02139, USA., Kirsch KH; The Ragon Institute of MGH, MIT, and Harvard University, Cambridge, MA 02139, USA., Weldon SR; The Ragon Institute of MGH, MIT, and Harvard University, Cambridge, MA 02139, USA., Groschel B; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA., Nogal B; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; Department of Integrative, Structural and Computational Biology, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA., Ozorowski G; Department of Integrative, Structural and Computational Biology, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA., Bangaru S; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; Department of Integrative, Structural and Computational Biology, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA., Phelps N; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA., Adachi Y; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA., Eskandarzadeh S; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA., Kubitz M; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA., Burton DR; The Ragon Institute of MGH, MIT, and Harvard University, Cambridge, MA 02139, USA; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA., Lingwood D; The Ragon Institute of MGH, MIT, and Harvard University, Cambridge, MA 02139, USA., Schmidt AG; The Ragon Institute of MGH, MIT, and Harvard University, Cambridge, MA 02139, USA; Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA., Nair U; The Ragon Institute of MGH, MIT, and Harvard University, Cambridge, MA 02139, USA., Ward AB; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; Department of Integrative, Structural and Computational Biology, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA., Schief WR; The Ragon Institute of MGH, MIT, and Harvard University, Cambridge, MA 02139, USA; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, San Diego, CA 92037, USA., Batista FD; The Ragon Institute of MGH, MIT, and Harvard University, Cambridge, MA 02139, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA; Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: fbatista1@mgh.harvard.edu.

Publikováno v: Immunity [Immunity] 2022 Oct 11; Vol. 55 (10), pp. 1856-1871.e6. Date of Electronic Publication: 2022 Aug 04.

INTERVENCIONES EN LOS TRATAMIENTOS FARMACOLÓGICOS EN UNA RESIDENCIA SOCIOSANITARIA: PERIODO 2011-2014

Autor: de la Nogal B, Rodríguez E, Cubelos N, Fernández T, Juan P, Cubillas M, González E, Marcos E, Villaverde R, Picon M, Peque Y, Yebra R, Pérez P, Sánchez P, Canedo C, López L, Domínguez I, García L, López B, Vázquez S, Valdueza J, Noguerol M, Martínez V, Rodríguez M

Publikováno v: Electronic Journal of Biomedicine, Vol 1, Iss 1, Pp 16-21 (2015)

This article describes prospectively the pharmacological interventions carried out from October 2011 to December 2014 on elderly people in a public social-health center. This work is made by the multidisciplinary team (doctors and nurses of the socia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::dcc0fc956f5738bf3e7d56c4e97c3693
http://biomed.uninet.edu/2015/n1/nogal.html